209 related articles for article (PubMed ID: 16109772)
1. Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.
Chen G; Bhojani MS; Heaford AC; Chang DC; Laxman B; Thomas DG; Griffin LB; Yu J; Coppola JM; Giordano TJ; Lin L; Adams D; Orringer MB; Ross BD; Beer DG; Rehemtulla A
Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12507-12. PubMed ID: 16109772
[TBL] [Abstract][Full Text] [Related]
2. Nuclear localized phosphorylated FADD induces cell proliferation and is associated with aggressive lung cancer.
Bhojani MS; Chen G; Ross BD; Beer DG; Rehemtulla A
Cell Cycle; 2005 Nov; 4(11):1478-81. PubMed ID: 16258269
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities.
Alappat EC; Feig C; Boyerinas B; Volkland J; Samuels M; Murmann AE; Thorburn A; Kidd VJ; Slaughter CA; Osborn SL; Winoto A; Tang WJ; Peter ME
Mol Cell; 2005 Aug; 19(3):321-32. PubMed ID: 16061179
[TBL] [Abstract][Full Text] [Related]
4. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
[TBL] [Abstract][Full Text] [Related]
5. Regulation of TNF-related apoptosis-inducing ligand-mediated death-signal pathway in human beta cells by Fas-associated death domain and nuclear factor kappaB.
Ou D; Wang X; Metzger DL; Robbins M; Huang J; Jobin C; Chantler JK; James RF; Pozzilli P; Tingle AJ
Hum Immunol; 2005 Jul; 66(7):799-809. PubMed ID: 16112027
[TBL] [Abstract][Full Text] [Related]
6. Expression of nuclear and cytoplasmic phosphorylated FADD in gastric cancers.
Yoo NJ; Lee SH; Jeong EG; Lee JW; Soung YH; Nam SW; Kim SH; Lee JY; Lee SH
Pathol Res Pract; 2007; 203(2):73-8. PubMed ID: 17207586
[TBL] [Abstract][Full Text] [Related]
7. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
[TBL] [Abstract][Full Text] [Related]
9. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
[TBL] [Abstract][Full Text] [Related]
10. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer.
Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662
[TBL] [Abstract][Full Text] [Related]
12. Multiple functions of FADD in apoptosis, NF-κB-related signaling, and heart development in Xenopus embryos.
Sakamaki K; Takagi C; Kitayama A; Kurata T; Yamamoto TS; Chiba K; Kominami K; Jung SK; Okawa K; Nozaki M; Kubota HY; Ueno N
Genes Cells; 2012 Nov; 17(11):875-96. PubMed ID: 23025414
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer.
Bowman BM; Sebolt KA; Hoff BA; Boes JL; Daniels DL; Heist KA; Galbán CJ; Patel RM; Zhang J; Beer DG; Ross BD; Rehemtulla A; Galbán S
Sci Signal; 2015 Jan; 8(361):ra9. PubMed ID: 25628462
[TBL] [Abstract][Full Text] [Related]
14. Genetic disruption of KEAP1/CUL3 E3 ubiquitin ligase complex components is a key mechanism of NF-kappaB pathway activation in lung cancer.
Thu KL; Pikor LA; Chari R; Wilson IM; Macaulay CE; English JC; Tsao MS; Gazdar AF; Lam S; Lam WL; Lockwood WW
J Thorac Oncol; 2011 Sep; 6(9):1521-9. PubMed ID: 21795997
[TBL] [Abstract][Full Text] [Related]
15. Metallothionein 2A an interactive protein linking phosphorylated FADD to NF-κB pathway leads to colorectal cancer formation.
Marikar FM; Jin G; Sheng W; Ma D; Hua Z
Chin Clin Oncol; 2016 Dec; 5(6):76. PubMed ID: 28061540
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer.
Wang Y; Dong QZ; Fu L; Stoecker M; Wang E; Wang EH
Mol Carcinog; 2013 Nov; 52(11):890-9. PubMed ID: 22753141
[TBL] [Abstract][Full Text] [Related]
17. A novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NF-κB.
Schinske KA; Nyati S; Khan AP; Williams TM; Johnson TD; Ross BD; Tomás RP; Rehemtulla A
Mol Cancer Ther; 2011 Oct; 10(10):1807-17. PubMed ID: 21859840
[TBL] [Abstract][Full Text] [Related]
18. Mutation of FADD gene is rare in human colon and stomach cancers.
Soung YH; Lee JW; Kim SY; Nam SW; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
APMIS; 2004 Sep; 112(9):595-7. PubMed ID: 15601308
[TBL] [Abstract][Full Text] [Related]
19. Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling.
Kuo SH; Chou CH; Cheng AL; Wang CW; Chen YH; Chen RJ
Gynecol Oncol; 2012 Aug; 126(2):245-51. PubMed ID: 22564715
[TBL] [Abstract][Full Text] [Related]
20. SPOP promotes FADD degradation and inhibits NF-κB activity in non-small cell lung cancer.
Luo J; Chen B; Gao CX; Xie HK; Han CN; Zhou CC
Biochem Biophys Res Commun; 2018 Sep; 504(1):289-294. PubMed ID: 30190126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
